Loading...

Atlas Arteria

ASX:ALX
Snowflake Description

Limited growth unattractive dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ALX
ASX
A$5B
Market Cap
Add to portfolio
  1. Home
    2. ›
  2. AU
    3. ›
  3. Transportation
Last updated 2019/04/24 10:34
Company description

Atlas Arteria Limited invests in infrastructure and non-infrastructure assets. The last earnings update was 55 days ago. More info.

Find similar companies

Add to Portfolio Compare Print
ALX Share Price and Events
7 Day Returns
4.8%
ASX:ALX
0.8%
Oceania Infrastructure
0.5%
AU Market
1 Year Returns
19.6%
ASX:ALX
19.7%
Oceania Infrastructure
4.9%
AU Market
ALX Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Atlas Arteria (ALX) 4.8% 2.1% 12.2% 19.6% 53.8% 131.5%
Oceania Infrastructure 0.8% 3.4% 10.7% 19.7% 22.8% 85%
AU Market 0.5% 1.9% 8% 4.9% 19.5% 6.3%
1 Year Return vs Industry and Market
  • ALX outperformed the Market in Australia which returned 4.9% over the past year.
Price Volatility
ALX
Industry
5yr Volatility vs Market

Value

 Is Atlas Arteria undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Atlas Arteria to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Atlas Arteria.

ASX:ALX Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.5%
Perpetual Growth Rate 10-Year AU Government Bond Rate 2.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ASX:ALX
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AU Govt Bond Rate 2.3%
Equity Risk Premium S&P Global 6%
Infrastructure Unlevered Beta Simply Wall St/ S&P Global 0.99
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.991 (1 + (1- 30%) (45.14%)) 		1.204
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)		 1.2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.31% + (1.204 * 5.96%) 		9.49%

Discounted Cash Flow Calculation for ASX:ALX using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Atlas Arteria is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

ASX:ALX DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 9.49%)
2019 292.62 Analyst x2 267.26
2020 316.57 Analyst x2 264.08
2021 384.00 Analyst x1 292.57
2022 438.44 Est @ 14.18% 305.10
2023 484.99 Est @ 10.62% 308.24
2024 524.40 Est @ 8.13% 304.41
2025 557.87 Est @ 6.38% 295.77
2026 586.66 Est @ 5.16% 284.08
2027 611.92 Est @ 4.31% 270.63
2028 634.61 Est @ 3.71% 256.34
Present value of next 10 years cash flows A$2,848.47
ASX:ALX DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$634.61 × (1 + 2.31%) ÷ (9.49% – 2.31%) 		A$9,047.29
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$9,047.29 ÷ (1 + 9.49%)10 		A$3,654.53
ASX:ALX Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$2,848.47 + A$3,654.53 		A$6,503.00
Equity Value per Share
(AUD)		 = Total value / Shares Outstanding
= A$6,503.00 / 683.26 		A$9.52
ASX:ALX Discount to Share Price
Calculation Result
Value per share (AUD) From above. A$9.52
Current discount Discount to share price of A$7.20
= -1 x (A$7.20 - A$9.52) / A$9.52 		24.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Atlas Arteria is available for.
Intrinsic value
24%
Share price is A$7.2 vs Future cash flow value of A$9.52
Current Discount Checks
For Atlas Arteria to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Atlas Arteria's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Atlas Arteria's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Atlas Arteria's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Atlas Arteria's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:ALX PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$0.10
ASX:ALX Share Price ** ASX (2019-04-24) in AUD A$7.2
Oceania Infrastructure Industry PE Ratio Median Figure of 8 Publicly-Listed Infrastructure Companies 23.1x
Australia Market PE Ratio Median Figure of 544 Publicly-Listed Companies 16.19x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Atlas Arteria.

ASX:ALX PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:ALX Share Price ÷ EPS (both in AUD)

= 7.2 ÷ 0.10

 70.39x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Atlas Arteria is overvalued based on earnings compared to the Oceania Infrastructure industry average.
  • Atlas Arteria is overvalued based on earnings compared to the Australia market.
Price based on expected Growth
Does Atlas Arteria's expected growth come at a high price?
Raw Data
ASX:ALX PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 70.39x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts		 17.1%per year
Oceania Infrastructure Industry PEG Ratio Median Figure of 5 Publicly-Listed Infrastructure Companies 4.08x
Australia Market PEG Ratio Median Figure of 359 Publicly-Listed Companies 1.38x

*Line of best fit is calculated by linear regression .

ASX:ALX PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 70.39x ÷ 17.1%

 4.13x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Atlas Arteria is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Atlas Arteria's assets?
Raw Data
ASX:ALX PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$3.21
ASX:ALX Share Price * ASX (2019-04-24) in AUD A$7.2
Oceania Infrastructure Industry PB Ratio Median Figure of 8 Publicly-Listed Infrastructure Companies 1.95x
Australia Market PB Ratio Median Figure of 1,676 Publicly-Listed Companies 1.68x
ASX:ALX PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:ALX Share Price ÷ Book Value per Share (both in AUD)

= 7.2 ÷ 3.21

 2.24x

* Primary Listing of Atlas Arteria.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Atlas Arteria is overvalued based on assets compared to the Oceania Infrastructure industry average.
X
Value checks
We assess Atlas Arteria's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Infrastructure industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Infrastructure industry average (and greater than 0)? (1 check)
    5. Atlas Arteria has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Atlas Arteria expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Atlas Arteria expected to grow at an attractive rate?
  • Atlas Arteria's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
  • Atlas Arteria's earnings growth is expected to exceed the Australia market average.
  • Atlas Arteria's revenue growth is positive but not above the Australia market average.
Annual Growth Rates Comparison
Raw Data
ASX:ALX Future Growth Rates Data Sources
Data Point Source Value (per year)
ASX:ALX Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 17.1%
ASX:ALX Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 2.2%
Oceania Infrastructure Industry Earnings Growth Rate Market Cap Weighted Average 14.1%
Oceania Infrastructure Industry Revenue Growth Rate Market Cap Weighted Average 1.6%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.7%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:ALX Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:ALX Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 162 505 212 1
2022-12-31 155 456 199 1
2021-12-31 151 415 314 2
2020-12-31 146 390 274 2
2019-12-31 142 409 225 2
ASX:ALX Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 146 23 60
2018-09-30 328 34 63
2018-06-30 120 46 67
2018-03-31 101 32 293
2017-12-31 83 18 520
2017-09-30 54 -4 564
2017-06-30 25 -25 608
2017-03-31 14 -20 417
2016-12-31 3 -16 225
2016-09-30 2 -14 162
2016-06-30 2 -13 99
2016-03-31 2 -27 92

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Atlas Arteria's earnings are expected to grow by 17.1% yearly, however this is not considered high growth (20% yearly).
  • Atlas Arteria's revenue is expected to grow by 2.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:ALX Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Atlas Arteria Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:ALX Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 0.31 0.31 0.31 1.00
2022-12-31 0.29 0.29 0.29 1.00
2021-12-31 0.36 0.46 0.27 2.00
2020-12-31 0.40 0.48 0.25 4.00
2019-12-31 0.33 0.42 0.20 4.00
ASX:ALX Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31
2018-09-30
2018-06-30 0.10
2018-03-31 0.47
2017-12-31 0.88
2017-09-30 0.99
2017-06-30 1.12
2017-03-31 0.78
2016-12-31 0.43
2016-09-30 0.31
2016-06-30 0.19
2016-03-31 0.18

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Atlas Arteria is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Atlas Arteria's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Oceania market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Oceania market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Atlas Arteria has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Atlas Arteria performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Atlas Arteria's growth in the last year to its industry (Infrastructure).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Atlas Arteria has delivered over 20% year on year earnings growth in the past 5 years.
  • Atlas Arteria's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Atlas Arteria's 1-year earnings growth is negative, it can't be compared to the Oceania Infrastructure industry average.
Earnings and Revenue History
Atlas Arteria's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Atlas Arteria Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:ALX Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 145.99 59.85
2018-09-30 327.71 63.19 33.65
2018-06-30 119.66 66.53 115.70
2018-03-31 101.44 293.06 82.05
2017-12-31 83.23 519.58 48.41
2017-09-30 53.81 564.04 13.26
2017-06-30 24.51 608.49 -21.89
2017-03-31 13.60 416.80 39.76
2016-12-31 2.69 225.11 101.40
2016-09-30 2.27 162.04 134.31
2016-06-30 1.84 98.97 167.22
2016-03-31 2.03 92.03 98.28
2015-12-31 2.21 85.08 29.34
2015-09-30 2.52 71.35 27.42
2015-06-30 2.83 57.62 25.50
2015-03-31 2.48 3.53 54.21
2014-12-31 2.12 -50.56 82.92
2014-06-30 1.71 -47.41 83.27
2014-03-31 1.30 -2.74 52.73
2013-12-31 0.89 41.93 22.20
2013-06-30 0.25 5.08 17.78
2013-03-31 0.32 -26.50 16.98
2012-12-31 0.38 -58.08 16.17
2012-09-30 48.87 -157.91 16.32
2012-06-30 47.04 -224.85 14.88

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Atlas Arteria has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Atlas Arteria used its assets less efficiently than the Oceania Infrastructure industry average last year based on Return on Assets.
  • It is difficult to establish if Atlas Arteria improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Atlas Arteria's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Infrastructure industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Atlas Arteria has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Atlas Arteria's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Atlas Arteria's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Atlas Arteria is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Atlas Arteria's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Atlas Arteria's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Atlas Arteria Company Filings, last reported 3 months ago.

ASX:ALX Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 2,328.51 2,192.78 186.47
2018-09-30 2,328.51 2,192.78 186.47
2018-06-30 2,152.60 1,873.54 155.96
2018-03-31 2,152.60 1,873.54 155.96
2017-12-31 2,162.08 1,734.64 122.69
2017-09-30 2,162.08 1,734.64 122.69
2017-06-30 1,621.17 1,498.60 122.55
2017-03-31 1,621.17 1,498.60 122.55
2016-12-31 1,073.00 0.00 223.37
2016-09-30 1,073.00 0.00 223.37
2016-06-30 859.67 0.00 221.04
2016-03-31 859.67 0.00 221.04
2015-12-31 864.96 0.00 65.38
2015-09-30 864.96 0.00 65.38
2015-06-30 816.50 0.00 43.74
2015-03-31 816.50 0.00 43.74
2014-12-31 822.89 0.00 30.12
2014-06-30 734.86 0.00 21.99
2014-03-31 734.86 0.00 21.99
2013-12-31 875.56 0.00 17.66
2013-06-30 798.15 0.00 16.90
2013-03-31 798.15 0.00 16.90
2012-12-31 -980.59 2,514.15 56.00
2012-09-30 -980.59 2,514.15 56.00
2012-06-30 -919.42 2,428.08 58.96
  • Atlas Arteria's level of debt (94.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 94.2% today).
  • Debt is not well covered by operating cash flow (1.1%, less than 20% of total debt).
  • Unable to confirm if the interest payments on Atlas Arteria's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Atlas Arteria's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
    7. Atlas Arteria has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Atlas Arteria's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.17%
Current annual income from Atlas Arteria dividends. Estimated to be 5.84% next year.
If you bought A$2,000 of Atlas Arteria shares you are expected to receive A$83 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Atlas Arteria's pays a higher dividend yield than the bottom 25% of dividend payers in Australia (2.52%).
  • Atlas Arteria's dividend is below the markets top 25% of dividend payers in Australia (5.72%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:ALX Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Oceania Infrastructure Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 3.8%
Australia Market Average Dividend Yield Market Cap Weighted Average of 417 Stocks 4.3%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.5%
Australia Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:ALX Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 0.56 2.00
2022-12-31 0.50 2.00
2021-12-31 0.46 7.00
2020-12-31 0.41 8.00
2019-12-31 0.30 5.00
ASX:ALX Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-03-18 0.300 4.236
2019-02-27 0.300 4.280
2018-09-17 0.240 3.598
2018-03-28 0.240 3.725
2017-09-13 0.200 3.463
2017-03-23 0.190 3.386
2016-09-15 0.180 3.755
2016-03-10 0.190 3.662
2015-09-14 0.160 3.939
2015-02-25 0.164 4.936
2014-03-11 0.100 3.196
2013-09-11 0.066 2.483
2013-03-20 0.048 2.480

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Atlas Arteria has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Atlas Arteria only paid a dividend in the past 6 years.
Current Payout to shareholders
What portion of Atlas Arteria's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (5.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are not well covered by earnings (1x coverage).
X
Income/ dividend checks
We assess Atlas Arteria's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Atlas Arteria afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
    7. Atlas Arteria has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Atlas Arteria's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Graeme Bevans
AGE 60
TENURE AS CEO 0 years
CEO Bio

Mr. Graeme Francis Bevans serves as Chief Executive Officer and Director at Atlas Arteria Limited since April 1, 2019. Mr. Bevans was a Partner at Alinda Capital Partners LLC since 2010. Mr. Bevans focused on Infrastructure investments. Mr. Bevans has over 20 years’ experience in infrastructure. He has over 25 years of international experience in corporate banking and infrastructure investing. Prior to that, he served as a Vice President and Head of Infrastructure Investing at Canada Pension Plan Investment Board. Mr. Bevans was responsible for leading the development of the infrastructure portfolio in the private investments department. Mr. Bevans served as the Head of Infrastructure Investing at Industry Funds Management Pty Ltd. (IFM). Previously, he served as a Director of Capital Markets at AIDC, working extensively in Asia, Europe and the United States. Mr. Bevans served as an Executive Director at Copernican Securities Pty Ltd, where he advised on infrastructure investment financing. He served as a Director of Osprey Holdco Ltd. He served as Head of Infrastructure Investing at IFM Investors Pty Ltd. He served as Non-Executive Director of AWG Plc until July 28, 2010. Mr. Bevans served as a Director of Broadcast Australia Pty Limited since July 2009. He served as a Director of Puget Sound Energy Inc., and of Puget Energy Inc. from February 6, 2009 to July 2010. Mr. Bevans served as a Director of Guardian Digital Communications Ltd from July 21, 2009 to July 31, 2010. He served as a Director of Anglian Water Group Limited until July 28, 2010. Mr. Bevans was a Non-Executive Director of Pacific Hydro Ltd. since August 2, 2004.

CEO Compensation
  • Insufficient data for Graeme to compare compensation growth.
  • Insufficient data for Graeme to establish whether their remuneration is reasonable compared to companies of similar size in Australia.
Management Team

Graeme Bevans

TITLE
CEO & Director
AGE
60

Nadine Lennie

TITLE
Chief Financial Officer
AGE
45

Vincent Portal-Barrault

TITLE
Chief Operating Officer

Phillipa Chen

TITLE
Head of Investor Relations

Clayton McCormack

TITLE
Company Secretary & General Counsel

Navleen Prasad

TITLE
Public Affairs Manager
Board of Directors Tenure

Average tenure and age of the Atlas Arteria board of directors in years:

2.8
Average Tenure
57
Average Age
  • The average tenure for the Atlas Arteria board of directors is less than 3 years, this suggests a new board.
Board of Directors

NL Scheinkestel

TITLE
Independent Non-Executive Chairman
COMPENSATION
A$210K
AGE
58
TENURE
4 yrs

Graeme Bevans

TITLE
CEO & Director
AGE
60

Debbie Goodin

TITLE
Independent Non-Executive Director
COMPENSATION
A$178K
AGE
51
TENURE
1.6 yrs

David Bartholomew

TITLE
Independent Non Executive Director
COMPENSATION
A$35K
AGE
57
TENURE
0.5 yrs

Jean-Georges Malcor

TITLE
Independent Non-Executive Director
COMPENSATION
A$25K
AGE
62
TENURE
0.4 yrs

Derek Stapley

TITLE
Independent Non-Executive Director of Macquarie Atlas Roads International Limited
AGE
57
TENURE
8.8 yrs

James Keyes

TITLE
Non-Executive Independent Director of Macquarie Atlas Roads International Limited
AGE
55
TENURE
6.2 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Atlas Arteria insiders in the past 3 months.
Show me more companies with insider buying in the Infrastructure industry
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
09. Apr 19 Sell FIL Limited Company 26. Sep 18 03. Apr 19 -9,788,638 A$7.30 A$0
09. Apr 19 Buy FIL Limited Company 01. Oct 18 27. Mar 19 2,367,330 A$7.34 A$0
02. Apr 19 Buy Jean-Georges Malcor Individual 26. Mar 19 26. Mar 19 17,000 A$7.28 A$123,785
21. Jun 18 Sell DBX Advisors LLC Company 31. May 18 31. May 18 -1,230 A$6.65 A$-8,180
21. Jun 18 Sell Deutsche Asset & Wealth Management Company 06. Jun 18 06. Jun 18 -1,052 A$6.32 A$-6,649
21. Jun 18 Buy Deutsche Asset & Wealth Management Company 12. Jun 18 12. Jun 18 260 A$6.30 A$1,638
21. Jun 18 Sell RREEF America L.L.C. Company 22. May 18 19. Jun 18 -621,500 A$6.78 A$0
21. Jun 18 Sell Deutsche Investment Management Americas Inc. Company 01. Jun 18 15. Jun 18 -10,298 A$6.54 A$0
21. Jun 18 Buy Deutsche Investment Management Americas Inc. Company 22. May 18 13. Jun 18 12,000 A$6.15 A$0
04. Jul 18 Buy FIL Limited Company 19. Mar 18 02. Jul 18 39,398,008 A$6.84 A$269,482,395
04. Jul 18 Sell Macquarie Investment Management Australia Limited Company 19. Jun 18 29. Jun 18 -307,692 A$6.78 A$0
04. Jul 18 Buy Macquarie Investment Management Australia Limited Company 19. Jun 18 02. Jul 18 195,559 A$6.85 A$0
04. Jul 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 02. Jul 18 02. Jul 18 -13,476,174 A$6.70 A$-90,302,488
04. Jul 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 19. Jun 18 02. Jul 18 -840,372 A$6.94 A$0
04. Jul 18 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 19. Jun 18 02. Jul 18 294,668 A$6.84 A$0
04. Jul 18 Buy Macquarie Capital Investment Management LLC Company 19. Jun 18 19. Jun 18 698,490 A$6.76 A$4,721,793
04. Jul 18 Sell Macquarie Investment Management Limited Company 20. Jun 18 26. Jun 18 -6 A$6.77 A$0
04. Jul 18 Buy Macquarie Investment Management Limited Company 20. Jun 18 26. Jun 18 6 A$6.77 A$0
04. Jul 18 Sell Macquarie Investment Management Limited Company 19. Jun 18 02. Jul 18 -216,890 A$6.94 A$0
04. Jul 18 Buy Macquarie Investment Management Limited Company 19. Jun 18 02. Jul 18 373,452 A$6.84 A$0
18. Jul 18 Sell Macquarie Investment Management Australia Limited Company 13. Jul 18 13. Jul 18 -432 A$6.46 A$-2,791
18. Jul 18 Buy Macquarie Investment Management Australia Limited Company 13. Jul 18 13. Jul 18 217 A$6.47 A$1,404
18. Jul 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 13. Jul 18 13. Jul 18 -7,177,137 A$6.51 A$-46,113,614
18. Jul 18 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 13. Jul 18 13. Jul 18 77,617 A$6.52 A$0
18. Jul 18 Buy Macquarie Investment Management Limited Company 13. Jul 18 13. Jul 18 2,169 A$6.49 A$0
04. Jul 18 Sell Magellan Asset Management Limited Company 12. Jun 18 12. Jun 18 -19,088 A$6.28 A$-119,815
04. Jul 18 Buy Magellan Asset Management Limited Company 07. Jun 18 02. Jul 18 135,048 A$6.72 A$876,891
02. Jul 18 Sell Lazard Asset Management LLC Company 12. Feb 18 28. Jun 18 -13,067,450 A$6.38 A$-83,316,416
02. Jul 18 Buy Lazard Asset Management LLC Company 07. Feb 18 21. May 18 5,773,756 A$5.73 A$33,080,234
17. Jul 18 Sell Macquarie Investment Management Australia Limited Company 03. Jul 18 12. Jul 18 -17,771 A$6.48 A$0
17. Jul 18 Buy Macquarie Investment Management Australia Limited Company 03. Jul 18 12. Jul 18 67,410 A$6.49 A$0
17. Jul 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 03. Jul 18 12. Jul 18 -6,725,009 A$6.56 A$0
17. Jul 18 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 03. Jul 18 12. Jul 18 262,226 A$6.50 A$0
17. Jul 18 Sell Macquarie Capital Investment Management LLC Company 09. Jul 18 09. Jul 18 -73,532 A$6.40 A$-470,605
17. Jul 18 Sell Macquarie Investment Management Limited Company 06. Jul 18 06. Jul 18 -615 A$6.50 A$-3,998
17. Jul 18 Buy Macquarie Investment Management Limited Company 06. Jul 18 06. Jul 18 615 A$6.50 A$3,998
17. Jul 18 Sell Macquarie Investment Management Limited Company 03. Jul 18 11. Jul 18 -17,703 A$6.52 A$0
17. Jul 18 Buy Macquarie Investment Management Limited Company 03. Jul 18 12. Jul 18 342,035 A$6.52 A$0
05. Nov 18 Sell Macquarie Investment Management Australia Limited Company 20. Jul 18 29. Oct 18 -1,011,791 A$7.21 A$0
05. Nov 18 Buy Macquarie Investment Management Australia Limited Company 24. Jul 18 31. Oct 18 642,092 A$7.13 A$0
05. Nov 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 16. Jul 18 31. Oct 18 -3,928,626 A$7.25 A$0
05. Nov 18 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 16. Jul 18 31. Oct 18 3,863,660 A$7.24 A$0
05. Nov 18 Sell Macquarie Capital Investment Management LLC Company 26. Jul 18 29. Aug 18 -156,273 A$6.98 A$0
05. Nov 18 Buy Macquarie Capital Investment Management LLC Company 26. Jul 18 29. Oct 18 896,412 A$6.99 A$0
05. Nov 18 Sell Macquarie Investment Management Limited Company 16. Jul 18 31. Oct 18 -6,820,540 A$7.25 A$0
05. Nov 18 Buy Macquarie Investment Management Limited Company 16. Jul 18 31. Oct 18 6,596,544 A$7.24 A$0
05. Oct 18 Buy Derek Stapley Individual 27. Sep 18 27. Sep 18 5,000 A$6.80 A$34,000
04. Jul 18 Sell Lazard Asset Management LLC Company 29. Jun 18 02. Jul 18 -5,823,952 A$6.51 A$-37,261,620
07. Mar 19 Buy Nora Scheinkestel Individual 05. Mar 19 05. Mar 19 2,867 A$6.90 A$19,782
04. Mar 19 Buy Debra Goodin Individual 04. Mar 19 04. Mar 19 14,476 A$6.88 A$99,595
04. Mar 19 Buy David Bartholomew Individual 01. Mar 19 01. Mar 19 8,730 A$6.90 A$60,237
20. Sep 18 Sell Deutsche Asset Management S.A. Company 08. Jun 18 18. Sep 18 -279,310 A$7.24 A$0
22. May 18 Buy Deutsche Asset Management S.A. Company 10. May 18 10. May 18 39,100 A$6.35 A$248,285
20. Sep 18 Buy Deutsche Asset Management S.A. Company 29. Jun 18 06. Jul 18 120,340 A$6.32 A$0
18. Feb 19 Sell Macquarie Investment Management Australia Limited Company 02. Nov 18 11. Feb 19 -400,623 A$7.03 A$0
18. Feb 19 Buy Macquarie Investment Management Australia Limited Company 21. Nov 18 31. Jan 19 691,183 A$6.72 A$0
18. Feb 19 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 01. Nov 18 21. Dec 18 -1,659,287 A$7.05 A$0
18. Feb 19 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 01. Nov 18 21. Dec 18 1,526,422 A$7.01 A$0
18. Feb 19 Sell Macquarie Capital Investment Management LLC Company 12. Nov 18 11. Feb 19 -97,603 A$6.85 A$-79,960
18. Feb 19 Buy Macquarie Capital Investment Management LLC Company 05. Nov 18 13. Feb 19 835,530 A$6.98 A$152,733
18. Feb 19 Sell Macquarie Investment Management Limited Company 06. Nov 18 08. Feb 19 -3,581,939 A$6.95 A$0
18. Feb 19 Buy Macquarie Investment Management Limited Company 06. Nov 18 08. Feb 19 3,581,939 A$6.95 A$0
18. Feb 19 Sell Macquarie Investment Management Limited Company 01. Nov 18 13. Feb 19 -2,748,945 A$7.00 A$0
18. Feb 19 Buy Macquarie Investment Management Limited Company 01. Nov 18 13. Feb 19 2,087,075 A$7.00 A$0
20. Sep 18 Buy Deutsche Investment Management Americas Inc. Company 22. May 18 05. Sep 18 20,227 A$6.81 A$0
22. May 18 Buy Deutsche Investment Management Americas Inc. Company 15. May 18 16. May 18 74,461 A$6.23 A$0
20. Sep 18 Sell Deutsche Investment Management Americas Inc. Company 01. Jun 18 15. Jun 18 -10,298 A$6.39 A$0
16. Dec 18 Sell The Vanguard Group, Inc. Company 31. Aug 18 12. Dec 18 -113,960 A$6.98 A$-795,441
16. Dec 18 Buy The Vanguard Group, Inc. Company 13. Aug 18 11. Dec 18 1,209,849 A$7.26 A$8,784,614
22. May 18 Buy Wilsons Holding Company Pty Ltd., Asset Management Arm Company 17. May 18 18. May 18 10,400 A$6.04 A$0
05. Oct 18 Sell Magellan Asset Management Limited Company 12. Jun 18 21. Sep 18 -777,457 A$6.69 A$-5,202,590
05. Oct 18 Buy Magellan Asset Management Limited Company 07. Jun 18 03. Oct 18 1,415,253 A$7.23 A$10,237,232
25. Sep 18 Sell FIL Limited Company 04. Jul 18 17. Sep 18 -1,294,278 A$7.22 A$0
25. Sep 18 Buy FIL Limited Company 03. Jul 18 21. Sep 18 10,286,013 A$7.02 A$0
20. Sep 18 Sell DBX Advisors LLC Company 31. May 18 31. May 18 -1,230 A$6.65 A$-8,180
20. Sep 18 Sell Deutsche Asset & Wealth Management Company 06. Jun 18 13. Sep 18 -19,965 A$6.88 A$0
20. Sep 18 Buy Deutsche Asset & Wealth Management Company 12. Jun 18 06. Sep 18 941 A$6.71 A$0
20. Sep 18 Sell Deutsche Bank, Private Banking and Investment Banking Investments Company 22. May 18 06. Sep 18 -693,771 A$7.18 A$0
20. Sep 18 Buy Deutsche Bank, Private Banking and Investment Banking Investments Company 21. May 18 06. Sep 18 799,074 A$7.14 A$0
20. Sep 18 Sell RREEF America L.L.C. Company 22. May 18 11. Sep 18 -2,764,910 A$7.18 A$0
20. Sep 18 Buy RREEF America L.L.C. Company 04. Jun 18 18. Sep 18 10,002,400 A$7.24 A$0
21. Jun 18 Sell Macquarie Investment Management Australia Limited Company 20. Feb 18 18. Jun 18 -1,678,353 A$6.66 A$0
21. Jun 18 Buy Macquarie Investment Management Australia Limited Company 19. Feb 18 18. Jun 18 2,704,349 A$6.67 A$0
21. Jun 18 Sell Macquarie Capital Investment Management LLC Company 05. Jun 18 05. Jun 18 -12,203 A$6.42 A$-78,343
21. Jun 18 Buy Macquarie Capital Investment Management LLC Company 21. Mar 18 18. Jun 18 7,740,415 A$6.65 A$0
21. Jun 18 Sell Macquarie Group, Ltd., Banking & Securities Investments Company 19. Feb 18 18. Jun 18 -2,879,385 A$6.67 A$0
21. Jun 18 Buy Macquarie Group, Ltd., Banking & Securities Investments Company 21. Feb 18 18. Jun 18 2,680,232 A$6.66 A$0
21. Jun 18 Sell Macquarie Investment Management Limited Company 20. Feb 18 15. Jun 18 -123,987 A$6.58 A$0
21. Jun 18 Buy Macquarie Investment Management Limited Company 20. Feb 18 15. Jun 18 123,987 A$6.58 A$0
21. Jun 18 Sell Macquarie Investment Management Limited Company 19. Feb 18 18. Jun 18 -2,303,411 A$6.64 A$0
21. Jun 18 Buy Macquarie Investment Management Limited Company 19. Feb 18 18. Jun 18 2,147,240 A$6.67 A$0
08. Jun 18 Sell Magellan Asset Management Limited Company 20. Mar 18 11. May 18 -456,709 A$6.36 A$-2,905,353
08. Jun 18 Buy Magellan Asset Management Limited Company 09. Feb 18 06. Jun 18 823,430 A$6.57 A$5,406,888
30. Apr 18 Sell Wilsons Holding Company Pty Ltd., Asset Management Arm Company 27. Dec 17 26. Apr 18 -32,763,182 A$6.35 A$0
22. May 18 Sell Deutsche Asset & Wealth Management Company 15. May 18 15. May 18 -3,100 A$6.18 A$-19,158
22. May 18 Buy Deutsche Asset & Wealth Management Company 14. May 18 14. May 18 338 A$6.21 A$2,099
22. May 18 Sell Deutsche Bank, Private Banking and Investment Banking Investments Company 07. May 18 15. May 18 -39,856 A$6.41 A$0
22. May 18 Buy Deutsche Bank, Private Banking and Investment Banking Investments Company 04. May 18 08. May 18 28,058 A$6.47 A$0
22. May 18 Sell RREEF America L.L.C. Company 04. May 18 17. May 18 -291,720 A$6.40 A$0
22. May 18 Buy RREEF America L.L.C. Company 16. May 18 16. May 18 16,200 A$6.09 A$98,658
07. May 18 Buy DBX Advisors LLC Company 30. Apr 18 30. Apr 18 945 A$6.43 A$6,076
07. May 18 Sell Deutsche Bank, Private Banking and Investment Banking Investments Company 30. Apr 18 30. Apr 18 -2,307 A$6.39 A$-14,742
07. May 18 Buy Deutsche Bank, Private Banking and Investment Banking Investments Company 01. May 18 01. May 18 5,271 A$6.45 A$33,998
07. May 18 Buy RREEF America L.L.C. Company 02. May 18 03. May 18 29,000 A$6.47 A$187,121
07. May 18 Buy Deutsche Investment Management Americas Inc. Company 26. Apr 18 03. May 18 48,116 A$6.44 A$309,838
30. Apr 18 Buy DBX Advisors LLC Company 09. Feb 18 26. Apr 18 2,830 A$6.02 A$0
30. Apr 18 Buy Deutsche Asset & Wealth Management Company 26. Feb 18 26. Apr 18 110,849 A$6.18 A$0
30. Apr 18 Buy RREEF America L.L.C. Company 27. Dec 17 26. Apr 18 8,315,661 A$6.30 A$0
30. Apr 18 Buy Deutsche Investment Management Americas Inc. Company 27. Dec 17 26. Apr 18 4,833,715 A$6.30 A$0
X
Management checks
We assess Atlas Arteria's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
    5. Atlas Arteria has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Kind Of Shareholders Own Atlas Arteria Limited (ASX:ALX)?

The big shareholder groups in Atlas Arteria Limited (ASX:ALX) have power over the company. … Generally speaking, as a company grows, institutions will increase their ownership. … Taking a look at our data on the ownership groups (below), it's seems that.

Simply Wall St - –

Read This Before Selling Atlas Arteria Limited (ASX:ALX) Shares

Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. … So we'll take a look at whether insiders have been buying or selling shares in Atlas Arteria Limited (ASX:ALX). … The Last 12 Months Of Insider Transactions At Atlas Arteria.

Simply Wall St - –

Announcing: Atlas Arteria (ASX:ALX) Stock Increased An Energizing 127% In The Last Five Years

One great example is Atlas Arteria Limited (ASX:ALX) which saw its share price drive 127% higher over five years. … By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. … Over half a decade, Atlas Arteria managed to grow its earnings per share at 3.3% a year.

Simply Wall St - –

Read This Before Buying Atlas Arteria Limited (ASX:ALX) For Its Dividend

Historically, Atlas Arteria Limited (ASX:ALX) has paid a dividend to shareholders. … Does Atlas Arteria tick all the boxes of a great dividend stock? … Check out our latest analysis for Atlas Arteria

Simply Wall St - –

Should Atlas Arteria Limited (ASX:ALX) Focus On Improving This Fundamental Metric?

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Atlas Arteria Limited (ASX:ALX). … One way to conceptualize this, is that for each A$1 of shareholders' equity it has, the company made A$0.031 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St - –

Do Institutions Own Atlas Arteria Limited (ASX:ALX) Shares?

The big shareholder groups in Atlas Arteria Limited (ASX:ALX) have power over the company. … Generally speaking, as a company grows, institutions will increase their ownership. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St - –

Atlas Arteria Limited (ASX:ALX) Is Trading At A 23.54% Discount

by estimating the company's future cash flows and discounting them to their present value. … discounted cash flows (DCF). … If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model

Simply Wall St - –

Is Atlas Arteria Limited (ASX:ALX) A Financially Sound Company?

Stocks with market capitalization between $2B and $10B, such as Atlas Arteria Limited (ASX:ALX) with a size of AU$4.5b, do not attract as much attention from the investing community as do the small-caps and large-caps. … Don’t forget that this is a general and concentrated examination of Atlas Arteria’s financial health, so you should conduct further analysis. … View our latest analysis for Atlas Arteria

Simply Wall St - –

Should You Buy Atlas Arteria Limited (ASX:ALX) For Its Dividend?

A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … Historically, Atlas Arteria Limited (ASX:ALX) has been paying a dividend to shareholders. … Let's take a look at Atlas Arteria in more detail.

Simply Wall St - –

Do You Know Who Else Invests In Atlas Arteria Limited (ASX:ALX)?

Today, I will be analyzing Atlas Arteria Limited’s (ASX:ALX) recent ownership structure, an important but not-so-popular subject among individual investors. … The impact of a company's ownership structure affects both its short- and long-term performance. … ASX:ALX Ownership Summary August 30th 18

Simply Wall St - –

Company Info

Description

Atlas Arteria Limited invests in infrastructure and non-infrastructure assets. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited is based in Sydney, Australia.

Details
Name: Atlas Arteria Limited
ALX
Exchange: ASX
Founded:
A$4,858,012,294
683,264,739
Website: http://www.atlasarteria.com
Address: Atlas Arteria Limited
50 Martin Place,
Level 7,
Sydney,
New South Wales, 2000,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX ALX Stapled Securities Australian Securities Exchange AU AUD 25. Jan 2010
OTCPK MAQA.F Stapled Securities Pink Sheets LLC US USD 25. Jan 2010
DB M82 Stapled Securities Deutsche Boerse AG DE EUR 25. Jan 2010
CHIA ALX Stapled Securities Chi-X Australia AU AUD 25. Jan 2010
Number of employees
Current staff
Staff numbers
0
Atlas Arteria employees.
Industry
Highways and Railtracks
Transportation
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 10:34
End of day share price update: 2019/04/24 00:00
Last estimates confirmation: 2019/04/24
Last earnings filing: 2019/02/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Related Companies

© 2019 Simply Wall Street Pty Ltd, Community Design 2845206, US Design Patent #29/544/281, European Design Registration #2845206, Standard & Poor’s Financial Services LLC. All rights reserved.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2019, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2019)